Mirae Asset Global Etfs Holdings Ltd. Sarepta Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 36,871 shares of SRPT stock, worth $4.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,871Holding current value
$4.61 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.13 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$540 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$518 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$477 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...